retatrutide for diabetes type 2 More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide associated with improved glycemic

Fibre deserves its own mention because of how the combo changes eating

It is a hormone that your body naturally produces in the gut

Skillbck et al., 2017) indicate the vulnerability of the NVU in Alzheimers disease, the most common neurodegenerative disease (Muoio et al., 2014), and both protective and trophic functions of the neural barrier seem to be impaired (Balusu et al., 2016

The skinny on fat: lipolysis and fatty acid utilization in adipocytes

GPR146 deficiency confers a distinct metabolic profile characterized by protection against diet-induced obesity and hepatic steatosis, along with reduced circulating free fatty acid levels and suppression of inflammatory gene expression

Do we provide our bodies with the nutrients it needs to fight the daily stresses of life